Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CAP Median Bid Prices, Physician Indifference Likely Contributed To Vendors Spurning Contracts

This article was originally published in The Pink Sheet Daily

Executive Summary

BioScrip will be the only provider of Medicare Part B-covered drugs through the competitive acquisition program for three years.

You may also be interested in...



CMS Suspends Medicare Part B CAP As Specialty Distributors Avoid Program

Competitive acquisition program bidding for the 2009-2011 contract period fails to result in a vendor contract, so CMS will revamp program.

Part D Enrollment Deadline Approaches With Fewer Than 6 Mil. Eligibles Still Unenrolled

The federal government is on the verge of ensuring that 90% of Medicare-eligible people receive prescription drug coverage, HHS Secretary Leavitt said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS064115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel